Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells

Keyphrases

• B-cell Acute Lymphoblastic Leukemia (B-ALL) 100%
• Acute Lymphoblastic Leukemia Cells 100%
• Biological Characteristics 100%
• Drug Resistance 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Immunophenotyping 60%
• Leukemic Cells 40%
• L-asparaginase 40%
• Daunorubicin 40%
• T-cell Acute Lymphoblastic Leukemia (T-ALL) 40%
• Prednisolone 40%
• Prognostic Significance 40%
• ProB 40%
• Teniposide 40%
• Cellular Burden 40%
• Working Diagnosis 20%
• Initial Diagnosis 20%
• Prognostic Value 20%
• Ifosfamide 20%
• Doxorubicin 20%
• Mercaptopurine 20%
• Thioguanine 20%
• Young children 20%
• Better Prognosis 20%
• Mitoxantrone 20%
• Age Groups 20%
• Older children 20%
• Worse Prognosis 20%
• MTT Assay 20%
• Drug Resistance Profiles 20%
• Vindesine 20%
• Chemotherapeutic Regimens 20%
• Drug Susceptibility Testing 20%

Biochemistry, Genetics and Molecular Biology

• Drug Resistance 100%
• Immunophenotyping 50%
• Asparaginase 33%
• Daunorubicin 33%
• Teniposide 33%
• Prednisolone 33%
• Ifosfamide 16%
• Morphology 16%
• MTT Assay 16%
• Mercaptopurine 16%
• Doxorubicin 16%
• Dexamethasone 16%
• Tioguanine 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Lymphoblastic Leukemia 100%
• Drug Resistance 100%
• Daunorubicin 18%
• Asparaginase 18%
• Prednisolone 18%
• Teniposide 18%
• Doxorubicin 9%
• Ifosfamide 9%
• Vincristine 9%
• Dexamethasone 9%
• Tioguanine 9%
• Mercaptopurine 9%
• Mitoxantrone 9%
• Vindesine 9%